EGFR L718V (+)/T790M (-) as a Mechanism of Resistance in Patients with Metastatic Non-small-cell Lung Cancer with EGFR L858R Mutations Article

Raez, Luis E, Carracedo, Carlos, Drusbosky, Leylah M et al. (2021). EGFR L718V (+)/T790M (-) as a Mechanism of Resistance in Patients with Metastatic Non-small-cell Lung Cancer with EGFR L858R Mutations . 22(6), E817-E819. 10.1016/j.cllc.2021.03.018

cited authors

  • Raez, Luis E; Carracedo, Carlos; Drusbosky, Leylah M; Velez, Michel; Carlisle, Jennifer; Stinchcombe, Thomas

sustainable development goals

authors

publication date

  • November 16, 2021

keywords

  • Actionable mutations
  • Genetic aberrations
  • Genomic profile
  • Life Sciences & Biomedicine
  • Liquid biopsies
  • Next-generation sequencing (NGS)
  • OSIMERTINIB
  • Oncology
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • CIG MEDIA GROUP, LP

start page

  • E817

end page

  • E819

volume

  • 22

issue

  • 6